Across the pond...Nasdaq: KZIA, page-38

Also our weekly chart shows we are still trending up and this is likely to continue as we move into the mid August news/readout

This DiPG readout in August I think many realise could be quite an addition to our current excellent performance in GBM...

And it’s starting to confirm a pattern:
1). Third party clinician/scientists get excited
2). Clinicians start trials and fund them (if not internal)
3). Clinicians continue to run trials to readouts
4). Clinicians confirm reason for excitement in readouts
5). We get a confirmation of efficacy from hard data

Each condition for which we report a efficacious response adds to the patient and market potential of Paxalisib.

It’s all about the science!